$8.05
0.273.47%
Pre-Market: 6:09 PM EDT
Comments
Loading...
Lexeo Therapeutics (NASDAQ:LXEO) Stock, Earnings Estimates, EPS, And Revenue
Lexeo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-0.890
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Lexeo Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Lexeo Therapeutics (LXEO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $-0.89 | $-0.68 | -30.9 % |
| Jun 2024 | 2024-08-12 | $-0.64 | $-0.79 | 19.0 % |
| Mar 2024 | 2024-05-09 | $-0.77 | $-0.77 | 0.00 % |
| Dec 2023 | 2024-03-11 | $-0.86 | $-0.73 | -17.8 % |
Lexeo Therapeutics (LXEO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Lexeo Therapeutics (NASDAQ:LXEO) reporting earnings?
Lexeo Therapeutics (LXEO) is scheduled to report earnings on November 26, 2024. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Lexeo Therapeutics (NASDAQ:LXEO)?
The Actual EPS was $-0.89, which missed the estimate of $-0.68.
What were Lexeo Therapeutics’s (NASDAQ:LXEO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.